BellRock Brands Inc.
BellRock Brands Inc.
Your view on DXBRF
Overview
What the company does, where it operates, and who runs it.
About BellRock Brands Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Sat Joshi
- Headquarters
- 4880 Havana Street, Denver, CO, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Sat Joshi
- Headquarters
- 4880 Havana Street, Denver, CO, US
BellRock Brands Inc. develops, markets, and sells cannabis products in the United States, Canada, and internationally. It offers cannabis infused adult-use topicals, confections, edibles, beverages, and concentrates, as well as transdermal patches, tinctures, capsules, lotions, creams, other topicals, vapes, and cosmetic serums.
The company also provides branded hemp-infused products for humans and pets. Its brands include Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, Défoncé, and Rebel Coast.
The company was formerly known as Dixie Brands Inc. and changed its name to BellRock Brands Inc. in October 2020. BellRock Brands Inc. is headquartered in Denver, Colorado. As of October 10, 2022, BellRock Brands Inc. operates as a subsidiary of West 4th Holdings, LLC.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for BellRock Brands Inc., and the rating behind it. DXBRF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for BellRock Brands Inc.. Starting points for BellRock Brands Inc.: EPS -$0.16, beta -134.88 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for BellRock Brands Inc.. BellRock Brands Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for BellRock Brands Inc.. Trailing twelve-month EPS for BellRock Brands Inc. stands at -$0.16. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for BellRock Brands Inc.. BellRock Brands Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
BellRock Brands Inc. valued side by side against its closest peers. BellRock Brands Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold BellRock Brands Inc., and how their positions are changing. At a $10,978 market value, institutional positions materially move BellRock Brands Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by BellRock Brands Inc. executives and directors. Shares of BellRock Brands Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming BellRock Brands Inc.. BellRock Brands Inc. is a $10,978 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming BellRock Brands Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for BellRock Brands Inc.. Coverage tracks BellRock Brands Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.